1256132

Amgen, Inc. — FEI 2026154

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 13, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Thousand Oaks, CA (United States)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products
22921FDCA 582(b)(4)Systems in place to comply with verification requirements
360721 CFR 211.160(b)(2)Acceptance of in-process materials
457621 CFR 211.192No written record of investigation